| Product Name | MF | CAS | Details |
|---|
| Rottlerin | C30H28O8 | 82-08-6 | Details |
| 5-Oxo-4H,5H,6H,7H,8H-furo[3,2-b]azepine-3-carboxylic acid | C9H9NO4 | 180340-64-1 | Details |
| Cathepsin F antibody (FITC) | Details |
| 1-Methyl-4,5,6,7-tetrahydro-1H-1,2,3-benzotriazole-6-carboxylic acid | C8H11N3O2 | 1496734-87-2 | Details |
| Diethyldithiocarbamic acid silver salt | C5H10AgNS2 | 1470-61-7 | Details |
| N-alpha-Z-L-ornithine | C13H18N2O4 | 2640-58-6 | Details |
| METT10D Blocking Peptide | Details |
| H-Gly-Arg-Gly-Asp-Asn-Pro-OH | C23H38N10O10 | 114681-65-1 | Details |
| Chlorhexidine dihydrochloride impurity B | C16H26ClN9O | 1308292-89-8 | Details |
| 4H-Thieno[3,2-B]pyrrole-2-carboxylic Acid | C7H5NO2S | 1007386-84-6 | Details |
| 5-[4-(2H-Tetrazol-5-yl)phenyl]-2H-tetrazole | C8H6N8 | 6926-49-4 | Details |
| H-PHCVPRDLSWLDLEANMCLP-OH | Details |
| N-Carbamoyl-N'-methyl-N'-[2-[(5-methyl-1H-imidazol-4-yl)methylthio]ethyl]guanidine | C10H17N6OS | 52568-80-6 | Details |
| CSK substrate | Details |
| Tiglyl glycine | C7H11NO3 | 35842-45-6 | Details |
| 1-(Oxolan-3-yl)propan-2-ol | C7H14O2 | 1503525-13-0 | Details |
| 4-(Oxolan-3-yl)phenol | C10H12O2 | 66123-37-3 | Details |
| UTY Blocking Peptide | Details |
| [Phe7] Dynorphin A (1-7), amide, porcine | C43H59N11O8 | Details |
| 3-Chloro-4-methylaniline | C7H8ClN | 95-74-9 | Details |
| 2-Methylpyrrolidine-1-sulfonyl chloride | C5H10ClNO2S | 1184477-87-9 | Details |
| Flutamide | C11H11F3N2O3 | 13311-84-7 | Details |
| Bexarotene-13C4 Methyl Ester | C25H30O2 | 153559-48-9 | Details |
| Luteolin-7-O-D-glucopyranoside | C21H20O11 | 5373-11-5 | Details |
| TIM1 antibody (biotin) | Details |
| 4-(Methylsulfonyl)phenylhydrazine hydrochloride | C7H11ClN2O2S | 17852-67-4 | Details |
| N-Methyl-o-toluidine | C8H11N | 611-21-2 | Details |
| [1-(Oxolan-3-yl)-1H-1,2,3-triazol-4-yl]methanol | C7H11N3O2 | 1342544-21-1 | Details |
| WRAP53 antibody | Details |
| Methyl 6-hydroxy-1H-pyrrolo[2,3-b]pyridine-2-carboxylate hydrochloride | 2228465-53-8 | Details |
| 1-(2-(4-trifluoromethoxyphenoxy)acetyl)-4-(2-chlorophenyl)semicarbazide | C16H13ClF3N3O4 | 1022454-89-2 | Details |
| 2-(Thiophen-2-yl)-1H-1,3-benzodiazole-6-carbonitrile | C12H7N3S | 1421261-89-3 | Details |
| Recombinant Human SCGF-beta | Details |
| 3-((4-chlorophenyl)imino)indolin-2-one | C14H9ClN2O | 57644-24-3 | Details |
| o-Desphenyl sofosbuvir | C16H25FN3O9P | 1233335-82-4 | Details |
| Methyl 2-fluoro-4-hydroxybenzoate | C8H7FO3 | 197507-22-5 | Details |
| 4-(Chloromethyl)-3-ethyl-5-methyl-1,2-oxazole | C7H10ClNO | 40500-39-8 | Details |
| (3,5-Diiodo-Tyr1,D-Ala2,N-Me-Phe4,glycinol5)-Enkephalin acetate salt | C26H33I2N5O6 | 103213-42-9 | Details |
| 5-(Ethoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid | C17H18N2O6 | 74936-73-5 | Details |
| Mosapride citrate - Bio-X ? | C27H33ClFN3O10 | 112885-42-4 | Details |
| 1'-(tert-Butoxycarbonyl)-[1,4'-bipiperidine]-4-carboxylic acid | C16H28N2O4 | 201810-59-5 | Details |
| 2,4-Difluoro-3-methylbenzaldehyde | C8H6F2O | 847502-88-9 | Details |
| (2R)-1-Methyl-2-phenylaziridine | C9H11N | 1361410-99-2 | Details |
| Sodium 3-(4-chlorophenyl)-3-oxoprop-1-en-1-olate | C9H8ClNaO2 | 40160-35-8 | Details |
| RAB22A antibody | Details |
| Methyl 6-amino-3-methylpyridine-2-carboxylate | C8H10N2O2 | 1319069-28-7 | Details |
| RANTES antibody | Details |
| 1-(Furan-2-yl)-2-methoxyethan-1-amine | C7H11NO2 | 186029-07-2 | Details |
| 5-Methylfuran-2-carbothioamide | C6H7NOS | 1093076-67-5 | Details |
| CSN3 Blocking Peptide | Details |
| 3,4,5-Trichloropicolinonitrile | C6HCl3N2 | 139485-42-0 | Details |
| Cytarabine | C9H13N3O5 | 147-94-4 | Details |
| 3-Amino-1-(3-ethynylphenyl)thiourea | C9H9N3S | 1071638-49-7 | Details |
| 5,5-Dimethylspiro[2.3]hexan-1-amine hydrochloride | C8H16ClN | 2253640-65-0 | Details |
| Methyl 2-chloro-6-(trifluoromethyl)isonicotinate | C8H5ClF3NO2 | 1227594-40-2 | Details |
| 2-Chloro-1-{1-[3-(trifluoromethyl)phenyl]-1H-1,2,3-triazol-4-yl}ethan-1-one | C11H7ClF3N3O | 1384431-14-4 | Details |
| Toremifene-d6 citrate | C32H30ClD6NO8 | 1246833-71-5 | Details |
| 1-(1,2,3,4-Tetrahydroisoquinolin-2-yl)ethan-1-one | C11H13NO | 14028-67-2 | Details |
| (3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl)-N-(methyl((phenylamino)thioxomethyl)amino)formamide | C19H16Cl2N4O2S | 1023578-37-1 | Details |
| rac-tert-Butyl N-{[(1R,4R)-4-(bromomethyl)cyclohexyl]methyl}carbamate | C13H24BrNO2 | 198895-53-3 | Details |
| N-[4-Amino-3-(trifluoromethyl)phenyl]-4-fluorobenzamide | C14H10F4N2O | 926253-90-9 | Details |
| 4,5-Dimethoxyindole | C10H11NO2 | 30933-67-6 | Details |
| AS 19 | C18H25N3 | 1000578-26-6 | Details |
| 4,5,6,7-Tetrahydro-1,2-benzoxazol-3-amine | C7H10N2O | 1004-64-4 | Details |
| 5-(Aminomethyl)-2,3-dihydro-1H-inden-1-one hydrochloride | 2172488-42-3 | Details |
| OLC1 antibody | Details |
| 4-[(5-Ethyl-1,2,4-oxadiazol-3-yl)methoxy]benzoic acid | C12H12N2O4 | 1274122-56-3 | Details |
| 1-(7-Amino-2,3-dihydro-1,4-benzodioxin-6-yl)ethan-1-one | C10H11NO3 | 164526-13-0 | Details |
| N,5-Dimethyl-1,3-thiazol-2-amine hydrochloride | C5H9ClN2S | 2243507-93-7 | Details |
| 2-Bromo-1-(2-ethylphenyl)ethan-1-one | C10H11BrO | 593270-22-5 | Details |
| 2-Phenoxyethane-1-sulfonamide | C8H11NO3S | 100383-38-8 | Details |
| 2,3-Dihydro-3-oxo-5-isothiazolecarboxylic acid | C4H3NO3S | 1257444-26-0 | Details |
| 2-(3-{Hexahydro-1H-pyrrolo[2,1-c]morpholin-3-yl}-1H-1,2,4-triazol-5-yl)ethan-1-amine dihydrochloride | C11H20ClN5O | 1803570-82-2 | Details |
| FBPA antibody | Details |
| phrB protein (His tag) | Details |
| Esculeogenin A | C27H45NO4 | 854381-37-6 | Details |
| 1-(2-Chloro-4-nitrophenyl)-1h-pyrrole-2-carbaldehyde | C11H7ClN2O3 | 881041-26-5 | Details |
| Direct yellow PG | C13H14N3NaO4S | 6300-07-8 | Details |
| 1-(4-Methylpyrimidin-2-yl)-1H-pyrazol-3-amine | C8H9N5 | 1343861-23-3 | Details |
| 4-(3-Methylphenoxy)butanoic acid | C11H14O3 | 22180-01-4 | Details |
| 3-Fluoro-4-methoxybenzamide | C8H8FNO2 | 701640-04-2 | Details |
| Chlorhexidine digluconate EP Impurity L | Details |
| Hydrotalcite | CAlO9(-5) | 12304-65-3 | Details |
| 1-(2-Aminopropoxy)-4-fluorobenzene | C9H12FNO | 93750-33-5 | Details |
| 2-Methyl-5,6,7,8-tetrahydroquinazolin-5-amine | C9H13N3 | 927803-66-5 | Details |
| 3-Chloro-2,2-dimethyl-1-(4-phenylpiperazin-1-yl)propan-1-one | C15H21ClN2O | 1211489-57-4 | Details |
| N-(2-Aminoethyl)-4-bromobenzamide | C9H11BrN2O | 152535-04-1 | Details |
| 2-Iodo-4-methoxybenzaldehyde | C8H7IO2 | 105469-13-4 | Details |
| Pramipexole EP Impurity C | C20H32N6S2 | 1973461-14-1 | Details |
| 3-(Methoxymethyl)-1-methyl-1H-pyrazole-4-sulfonyl chloride | C6H9ClN2O3S | 1564710-51-5 | Details |
| Nbi 27914 hydrochloride | C18H20Cl4N4.ClH | 1215766-76-9 | Details |
| [1-(2-Bromophenyl)cyclohexyl]methanamine hydrochloride | C13H19BrClN | 1864073-45-9 | Details |
| 3,4,6-Tri-O-acetyl-1,2-O-ethylidene-b-D-mannopyranose | Details |
| 3-Benzylpyrrolidine-2,5-dione | C11H11NO2 | 66195-04-8 | Details |
| R 715 | C57H81N13O12 | 185052-09-9 | Details |
| 2-Chloroethyl methanesulfonylmethanesulfonate | C4H9ClO5S2 | 88343-72-0 | Details |
| H-FAQSIPK-OH | Details |
| 1-(2-Thiazolylazo)-2-naphthol | C13H9N3OS | 1147-56-4 | Details |
| JAK3-IN-6 | C19H18N4O3 | 1443235-95-7 | Details |
| STARD4 Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||